Crossmark Global Holdings, Inc. Charles River Laboratories International, Inc. Transaction History
Crossmark Global Holdings, Inc.
- $6.5 Billion
- Q3 2025
A detailed history of Crossmark Global Holdings, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 4,868 shares of CRL stock, worth $816,899. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,868
Previous 4,864
0.08%
Holding current value
$816,899
Previous $738,000
3.12%
% of portfolio
0.01%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding CRL
# of Institutions
645Shares Held
51.6MCall Options Held
194KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA5.84MShares$980 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$854 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.19MShares$535 Million0.09% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$365 Million0.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$307 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...